So far there is no clear treatment to effectively curb the progression of brain atrophy, even if given the relevant western drug treatment, the condition of brain atrophy will still gradually progress. Currently, the following western drugs are commonly used clinically for the treatment of brain atrophy: 1, acetylcholinesterase inhibitors, common drugs such as Anlishen and Aethlon, which are the first drugs approved by the FDA for the treatment of brain atrophy. 2, non-competitive N-methyl-D-monophosphate receptor antagonists, such as memantine. 3, other drugs, such as brain metabolism activators, potassium channel blockers, etc., commonly used clinically as western drugs There are olanzapine, cytarabine sodium, etc.